Stock screener
Filter the covered US universe by sector, size, profitability, dividends and performance. Every screen has its own shareable link — the address bar reflects your filters.
Showing 1–30 of 577 companies · sorted by market cap (high to low)
254 covered companies have no sector on record (3IN.L, AAF.L, AAL.L, ABDN.L, ABF.L, ADM.L, AEP.L, AJB.L, ALFA.L, AML.L, ANTO.L, AO.L), so they were not tested by this filter — a gap in our sector data, not evidence they do not belong here.
| Ticker | Company | Sector | Price | Market cap | P/E | Rev growth | Net margin | Div yield | 1y return |
|---|---|---|---|---|---|---|---|---|---|
| LLY | Lilly (Eli) | Health Care | $1,149.36 | $1.08T | 38.6 | +49.6% | +31.7% | +0.8% | +54.7% |
| JNJ | Johnson & Johnson | Health Care | $275.23 | $663.3B | 31.9 | +8.1% | +28.5% | +3.1% | +54.0% |
| ABBV | AbbVie | Health Care | $256.46 | $453.2B | 72.1 | +10.4% | +6.9% | +4.5% | +20.4% |
| MRK | Merck & Co. | Health Care | $150.33 | $370.9B | 120.1 | +4.6% | +28.1% | +2.9% | +78.9% |
| UNH | UnitedHealth Group | Health Care | $397.14 | $356.5B | 25.5 | +6.5% | +2.7% | +1.4% | +28.0% |
| AMGN | Amgen | Health Care | $437.23 | $236.4B | 27.2 | +9.1% | +21.0% | +3.2% | +56.1% |
| NVS | NOVARTIS AG | Health Care | $159.99 | $227.4B | 21.9 | +3.3% | n/a | +3.7% | +24.6% |
| TMO | Thermo Fisher Scientific | Health Care | $613.78 | $226.9B | 33.0 | +7.2% | +15.0% | +0.3% | +25.4% |
| NVO | NOVO NORDISK A S | Health Care | $46.60 | $206.0B | 11.4 | +5.6% | +33.1% | +1.0% | -17.0% |
| ABT | Abbott Laboratories | Health Care | $108.33 | $188.7B | 34.9 | +8.1% | +14.7% | +2.0% | -18.4% |
| GILD | Gilead Sciences | Health Care | $151.00 | $187.2B | n/a | +5.5% | +28.9% | +4.0% | +33.9% |
| AZN | ASTRAZENECA PLC | Health Care | $162.70 | $181.5B | 23.4 | +8.6% | +17.4% | +2.3% | -0.5% |
| PFE | Pfizer | Health Care | $28.45 | $162.2B | 37.7 | -0.2% | +12.4% | +5.4% | +15.9% |
| DHR | Danaher Corporation | Health Care | $207.66 | $146.0B | 36.9 | +4.6% | +14.7% | +0.5% | +4.3% |
| VRTX | Vertex Pharmaceuticals | Health Care | $546.12 | $138.4B | 31.8 | +10.2% | +32.9% | n/a | +37.6% |
| BMY | Bristol Myers Squibb | Health Care | $66.82 | $136.5B | 14.7 | +3.1% | +14.6% | +4.6% | +43.1% |
| ISRG | Intuitive Surgical | Health Care | $366.70 | $129.5B | 42.0 | +20.7% | +28.4% | n/a | -19.3% |
| CVS | CVS Health | Health Care | $96.74 | $123.7B | 25.6 | +7.4% | +0.4% | +3.5% | +31.3% |
| MDT | Medtronic | Health Care | $94.17 | $120.5B | 25.3 | +8.4% | +13.2% | +3.5% | +1.4% |
| SYK | Stryker Corporation | Health Care | $303.13 | $116.3B | 31.4 | +8.5% | +12.9% | +1.0% | -23.1% |
| MCK | McKesson Corporation | Health Care | $907.99 | $105.9B | 24.3 | +8.8% | +1.2% | +0.5% | +31.3% |
| HCA | HCA Healthcare | Health Care | $405.00 | $89.8B | 13.6 | +7.3% | +9.0% | +1.0% | -1.6% |
| ELV | Elevance Health | Health Care | $407.50 | $88.4B | 18.1 | +6.3% | +2.8% | +1.2% | +32.3% |
| REGN | Regeneron Pharmaceuticals | Health Care | $827.72 | $77.8B | 20.5 | +9.3% | +31.4% | +0.5% | +45.9% |
| CI | Cigna | Health Care | $282.52 | $74.7B | 11.7 | +7.8% | +2.2% | +1.7% | -7.1% |
| BSX | Boston Scientific | Health Care | $47.80 | $69.3B | 19.4 | +13.5% | +14.4% | n/a | -55.4% |
| COR | Cencora | Health Care | $330.95 | $63.2B | 24.6 | +5.1% | +0.5% | +1.0% | +13.1% |
| MRNA | Moderna | Health Care | $145.55 | $58.1B | n/a | -27.6% | -145.2% | n/a | +499.5% |
| CAH | Cardinal Health | Health Care | $247.18 | $57.5B | 37.8 | +12.9% | +0.7% | +1.9% | +65.5% |
| EW | Edwards Lifesciences | Health Care | $89.90 | $51.8B | 52.0 | +14.6% | +17.7% | n/a | +11.0% |
Every view here has its own address — copy the link from your browser to share exactly what you are looking at. Click a column header to sort.
Data: SEC EDGAR (filings) + market data (prices, fundamentals). Prices on this page are from the 2026-09-04 close or later — each figure is labelled with its own as-of date.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date. Past performance does not indicate future results.